2,275,000 Shares OrthoPediatrics Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2022 • Orthopediatrics Corp • Surgical & medical instruments & apparatus • New York
OrthoPediatrics Corp., a Delaware corporation (the “Company”) proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) 750,000 shares (the “Firm Shares”) of Common Stock, $0.00025 par value per share (the “Common Stock”) and (ii) 1,525,000 pre-funded warrants to purchase up to an aggregate of 1,525,000 shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.00025 per share, of the Company. The Company has also granted to the several Underwriters an option to purchase up to 341,250 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Shares.” The shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants are herein referred to as the “Warrant Shares.” The Shares, the Warrant Shares and the Pre-Funded War
